114 related articles for article (PubMed ID: 34668210)
1. Antiproliferative, proapoptotic, and tumor-suppressing effects of the novel anticancer agent alsevirone in prostate cancer cells and xenografts.
Khan II; Karshieva SS; Sokolova DV; Spirina TS; Zolottsev VA; Latysheva AS; Anisimova NY; Komarova MV; Yakunina MN; Nitetskaya TA; Misharin AY; Pokrovsky VS
Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100316. PubMed ID: 34668210
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo.
Wang J; Lu Z; Wu C; Li Y; Kong Y; Zhou R; Shi K; Guo J; Li N; Liu J; Song W; Wang H; Zhu M; Xu H
Prostate; 2019 Jan; 79(1):62-72. PubMed ID: 30242862
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of proliferation of prostate cancer cell line, PC-3, in vitro and in vivo using (-)-gossypol.
Zhang XQ; Huang XF; Mu SJ; An QX; Xia AJ; Chen R; Wu DC
Asian J Androl; 2010 May; 12(3):390-9. PubMed ID: 20081872
[TBL] [Abstract][Full Text] [Related]
4. N-substituted piperazinopyridylsteroid derivatives as abiraterone analogues inhibit growth and induce pro-apoptosis in human hormone-independent prostate cancer cell lines.
Brossard D; Zhang Y; Haider SM; Sgobba M; Khalid M; Legay R; Duterque-Coquillaud M; Galera P; Rault S; Dallemagne P; Moslemi S; El Kihel L
Chem Biol Drug Des; 2013 Nov; 82(5):620-9. PubMed ID: 23906044
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of a novel phenylbutyrate-based histone deacetylase inhibitor, (S)-HDAC-42, in prostate cancer.
Kulp SK; Chen CS; Wang DS; Chen CY; Chen CS
Clin Cancer Res; 2006 Sep; 12(17):5199-206. PubMed ID: 16951239
[TBL] [Abstract][Full Text] [Related]
6. Resistance to CYP17A1 inhibition with abiraterone in castration-resistant prostate cancer: induction of steroidogenesis and androgen receptor splice variants.
Mostaghel EA; Marck BT; Plymate SR; Vessella RL; Balk S; Matsumoto AM; Nelson PS; Montgomery RB
Clin Cancer Res; 2011 Sep; 17(18):5913-25. PubMed ID: 21807635
[TBL] [Abstract][Full Text] [Related]
7. Combination of Quercetin and 2-Methoxyestradiol Enhances Inhibition of Human Prostate Cancer LNCaP and PC-3 Cells Xenograft Tumor Growth.
Yang F; Song L; Wang H; Wang J; Xu Z; Xing N
PLoS One; 2015; 10(5):e0128277. PubMed ID: 26011145
[TBL] [Abstract][Full Text] [Related]
8. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
Xu Y; Dalrymple SL; Becker RE; Denmeade SR; Isaacs JT
Clin Cancer Res; 2006 Jul; 12(13):4072-9. PubMed ID: 16818707
[TBL] [Abstract][Full Text] [Related]
9. Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model.
Handratta VD; Vasaitis TS; Njar VC; Gediya LK; Kataria R; Chopra P; Newman D; Farquhar R; Guo Z; Qiu Y; Brodie AM
J Med Chem; 2005 Apr; 48(8):2972-84. PubMed ID: 15828836
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumour effects and pharmacokinetic profile of 17-(5'-isoxazolyl)androsta-4,16-dien-3-one (L-39) in mice: an inhibitor of androgen synthesis.
Nnane IP; Long BJ; Ling YZ; Grigoryev DN; Brodie AM
Br J Cancer; 2000 Jul; 83(1):74-82. PubMed ID: 10883671
[TBL] [Abstract][Full Text] [Related]
11. New benzothieno[2,3-
Khalil NA; Ahmed EM; Zaher AF; Sobh EA; El-Sebaey SA; El-Zoghbi MS
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1839-1859. PubMed ID: 34338119
[TBL] [Abstract][Full Text] [Related]
12. Anthocyanin induces apoptosis of DU-145 cells in vitro and inhibits xenograft growth of prostate cancer.
Ha US; Bae WJ; Kim SJ; Yoon BI; Hong SH; Lee JY; Hwang TK; Hwang SY; Wang Z; Kim SW
Yonsei Med J; 2015 Jan; 56(1):16-23. PubMed ID: 25510742
[TBL] [Abstract][Full Text] [Related]
13. A novel bis-indole destabilizes microtubules and displays potent in vitro and in vivo antitumor activity in prostate cancer.
Ahn S; Hwang DJ; Barrett CM; Yang J; Duke CB; Miller DD; Dalton JT
Cancer Chemother Pharmacol; 2011 Feb; 67(2):293-304. PubMed ID: 20383708
[TBL] [Abstract][Full Text] [Related]
14. R115777 (Zarnestra)/Zoledronic acid (Zometa) cooperation on inhibition of prostate cancer proliferation is paralleled by Erk/Akt inactivation and reduced Bcl-2 and bad phosphorylation.
Caraglia M; Marra M; Leonetti C; Meo G; D'Alessandro AM; Baldi A; Santini D; Tonini G; Bertieri R; Zupi G; Budillon A; Abbruzzese A
J Cell Physiol; 2007 May; 211(2):533-43. PubMed ID: 17192846
[TBL] [Abstract][Full Text] [Related]
15. RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.
Kumagai T; Ikezoe T; Gui D; O'Kelly J; Tong XJ; Cohen FJ; Said JW; Koeffler HP
Clin Cancer Res; 2004 Feb; 10(4):1508-20. PubMed ID: 14977855
[TBL] [Abstract][Full Text] [Related]
16. Prazosin displays anticancer activity against human prostate cancers: targeting DNA and cell cycle.
Lin SC; Chueh SC; Hsiao CJ; Li TK; Chen TH; Liao CH; Lyu PC; Guh JH
Neoplasia; 2007 Oct; 9(10):830-9. PubMed ID: 17971903
[TBL] [Abstract][Full Text] [Related]
17. Uptake and antitumoral effects of iodine and 6-iodolactone in differentiated and undifferentiated human prostate cancer cell lines.
Aranda N; Sosa S; Delgado G; Aceves C; Anguiano B
Prostate; 2013 Jan; 73(1):31-41. PubMed ID: 22576883
[TBL] [Abstract][Full Text] [Related]
18. Alpha-tocopheryl succinate (alpha-TOS) modulates human prostate LNCaP xenograft growth and gene expression in BALB/c nude mice fed two levels of dietary soybean oil.
Basu A; Grossie B; Bennett M; Mills N; Imrhan V
Eur J Nutr; 2007 Feb; 46(1):34-43. PubMed ID: 17180484
[TBL] [Abstract][Full Text] [Related]
19. Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
Yuan L; Huang X; Zhou K; Zhu X; Huang B; Qiu S; Cao K; Xu L
Prostate; 2019 Jun; 79(8):826-839. PubMed ID: 30889629
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Novel Non-Steroidal Cytochrome P450 17A1 Inhibitors as Potential Prostate Cancer Agents.
Wróbel TM; Rogova O; Andersen KL; Yadav R; Brixius-Anderko S; Scott EE; Olsen L; Jørgensen FS; Björkling F
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32660148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
